Kelyniam Global, Inc. (KLYG)
USD 0.18
(4.33%)
USD 0.18
(4.33%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 487.33 Thousand USD | 11.26% |
| 2022 | 559.87 Thousand USD | 81.72% |
| 2021 | 308.1 Thousand USD | -23.68% |
| 2020 | 403.71 Thousand USD | -31.82% |
| 2019 | 592.15 Thousand USD | 55.83% |
| 2018 | 380 Thousand USD | 125.39% |
| 2017 | 168.59 Thousand USD | -49.29% |
| 2016 | 332.46 Thousand USD | -5.24% |
| 2015 | 350.86 Thousand USD | -0.58% |
| 2014 | 352.9 Thousand USD | -29.21% |
| 2013 | 498.5 Thousand USD | 0.0% |
| 2007 | 46.12 Thousand USD | -35.25% |
| 2006 | 71.24 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 561.43 Thousand USD | 16.88% |
| 2024 Q1 | 480.34 Thousand USD | -22.89% |
| 2023 Q4 | 622.92 Thousand USD | -5.99% |
| 2023 Q1 | 605.38 Thousand USD | 8.13% |
| 2023 Q3 | 662.61 Thousand USD | 5.6% |
| 2023 FY | 622.92 Thousand USD | 11.26% |
| 2023 Q2 | 627.46 Thousand USD | 3.65% |
| 2022 Q3 | 423.68 Thousand USD | 10.92% |
| 2022 Q1 | 355.54 Thousand USD | 15.4% |
| 2022 FY | 559.87 Thousand USD | 81.72% |
| 2022 Q4 | 559.87 Thousand USD | 32.15% |
| 2022 Q2 | 381.96 Thousand USD | 7.43% |
| 2021 Q2 | 383.45 Thousand USD | -21.56% |
| 2021 Q3 | 222.68 Thousand USD | -41.93% |
| 2021 Q4 | 308.1 Thousand USD | 38.36% |
| 2021 FY | 308.1 Thousand USD | -23.68% |
| 2021 Q1 | 488.85 Thousand USD | 21.09% |
| 2020 Q2 | 592.82 Thousand USD | 23.79% |
| 2020 FY | 403.71 Thousand USD | -31.82% |
| 2020 Q4 | 403.71 Thousand USD | -38.71% |
| 2020 Q3 | 658.66 Thousand USD | 11.11% |
| 2020 Q1 | 478.87 Thousand USD | -19.13% |
| 2019 FY | 592.15 Thousand USD | 55.83% |
| 2019 Q4 | 592.15 Thousand USD | -11.51% |
| 2019 Q3 | 669.14 Thousand USD | 27.59% |
| 2019 Q2 | 524.46 Thousand USD | 12.63% |
| 2019 Q1 | 465.63 Thousand USD | 0.0% |
| 2018 FY | 380 Thousand USD | 125.39% |
| 2017 FY | 168.59 Thousand USD | -49.29% |
| 2016 FY | 332.46 Thousand USD | -5.24% |
| 2015 FY | 350.86 Thousand USD | -0.58% |
| 2014 Q4 | 354.39 Thousand USD | -17.47% |
| 2014 FY | 352.9 Thousand USD | -29.21% |
| 2014 Q3 | 429.38 Thousand USD | 0.0% |
| 2014 Q1 | 464.53 Thousand USD | 0.0% |
| 2013 Q1 | 542.56 Thousand USD | 0.0% |
| 2013 FY | 498.5 Thousand USD | 0.0% |
| 2013 Q2 | 667.7 Thousand USD | 23.07% |
| 2008 Q1 | 40.5 Thousand USD | -12.2% |
| 2007 Q3 | 53.12 Thousand USD | -13.8% |
| 2007 FY | 46.12 Thousand USD | -35.25% |
| 2007 Q1 | 61.01 Thousand USD | 0.0% |
| 2007 Q4 | 46.12 Thousand USD | -13.16% |
| 2007 Q2 | 61.62 Thousand USD | 0.99% |
| 2006 FY | 71.24 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| IR-Med Inc. | -606 Thousand USD | 180.418% |
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 14.82 Million USD | 96.713% |
| Medical Supply International USA, Inc. | 216.6 Thousand USD | -124.984% |
| Polarean Imaging plc | -5.94 Million USD | 108.195% |
| Avitar, Inc. | 5.17 Million USD | 90.576% |
| AVITA Medical, Inc. | -26.23 Million USD | 101.858% |
| Manhattan Scientifics, Inc. | -7000.00 USD | 7061.9% |
| Össur hf. | 395.08 Million USD | 99.877% |
| Zecotek Photonics Inc. | 2.76 Million USD | 82.359% |
| QHSLab, Inc. | 1.72 Million USD | 71.83% |
| Wellstar International, Inc. | 51.36 Million USD | 99.051% |
| Össur hf. | 395.08 Million USD | 99.877% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | -4.61 Million USD | 110.555% |
| Escalon Medical Corp. | 315.68 Thousand USD | -54.373% |
| Aurora Spine Corporation | 1.9 Million USD | 74.454% |
| BrainsWay Ltd. | -10.32 Million USD | 104.722% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 2.41 Million USD | 79.821% |
| Hamilton Thorne Ltd. | 18.12 Million USD | 97.311% |
| Vivos Inc. | -1.59 Million USD | 130.606% |
| MicroPort Scientific Corporation | 673.58 Million USD | 99.928% |
| REMSleep Holdings, Inc. | -540.98 Thousand USD | 190.082% |
| CYduct Diagnostics, Inc. | 640.19 Thousand USD | 23.878% |
| Nanomix Corporation | 11.38 Million USD | 95.721% |
| Theraclion SA | -5.86 Million EUR | 108.31% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 3.98 Million USD | 87.772% |
| Positron Corporation | 1.68 Million USD | 71.11% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.61 Million USD | 69.747% |
| Lombard Medical, Inc. | 11.49 Million USD | 95.76% |
| ALR Technologies Inc. | 19.14 Million USD | 97.455% |
| Stratec SE | 119.12 Million USD | 99.591% |
| Vycor Medical, Inc. | 1.05 Million USD | 53.718% |
| Heart Tronics, Inc. | 54.99 Thousand USD | -786.141% |
| Nu-Med Plus, Inc. | 93.19 Thousand USD | -422.923% |
| Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | 103.535% |
| SANUWAVE Health, Inc. | 30.14 Million USD | 98.383% |
| VMS Rehab Systems, Inc. | 133.52 USD | -364888.766% |
| Guided Therapeutics, Inc. | 1.46 Million USD | 66.78% |
| Ingen Technologies, Inc. | 630.91 Thousand USD | 22.758% |
| Odyssey Group International, Inc. | 2.1 Million USD | 76.879% |
| United American Healthcare Corporation | -9.32 Million USD | 105.225% |
| ECGI Holdings, Inc. | 3.17 Million USD | 84.633% |
| Capital Group Holdings, Inc. | -3508.00 USD | 13992.047% |
| ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | -85.567% |
| Urologix, Inc. | 4.61 Million USD | 89.44% |
| Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | 88.423% |
| Nexeon MedSystems Inc. | 3.33 Million USD | 85.371% |
| SS Innovations International, Inc. | 1.18 Million USD | 58.887% |
| Qualis Innovations, Inc. | 6671.00 USD | -7205.247% |
| Smith & Nephew plc | 2.77 Billion USD | 99.982% |
| NIOX Group Plc | -23.93 Million USD | 102.036% |
| Fuse Medical, Inc. | 1.75 Million USD | 72.24% |
| Broncus Holding Corporation | -81.42 Million USD | 100.599% |
| Brain Scientific Inc. | 2.11 Million USD | 76.967% |
| Pressure BioSciences, Inc. | 22.67 Million USD | 97.851% |
| Health Logic Interactive Inc. | 39.55 Thousand USD | -1131.977% |